19 June 2013
Keywords: gsk, hpv, vacc, provides, longest, protection, new
Article | 17 March 2008
New data demonstrate that UK drug major GlaxoSmithKline's cervical
cancer candidate vaccine, Cervarix, provides significant protection for
women against the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 March 2008
18 June 2013
© 2013 thepharmaletter.com